[Click here to subscribe to our NEW weekly newsletter!!]

Merck Boosts First-Quarter Profits
Seattle Times, WA - Apr 21, 2003
... During the first quarter, Merck won approval for Emend, to prevent nausea and vomiting
from chemotherapy effects, and got approval to also market Cozaar to ...

Merck Boosts First-Quarter Profits
Rapid City Journal, SD - Apr 21, 2003
... During the first quarter, Merck won approval for Emend, to prevent nausea and vomiting
from chemotherapy effects, and got approval to also market Cozaar to ...

Merck Boosts First-Quarter Profits
The Porterville Recorder, CA - Apr 21, 2003
... During the first quarter, Merck won approval for Emend, to prevent nausea and vomiting
from chemotherapy effects, and got approval to also market Cozaar to ...

Merck Boosts First-Quarter Profits
Springfield News Sun, OH - Apr 21, 2003
... During the first quarter, Merck won approval for Emend, to prevent nausea and vomiting
from chemotherapy effects, and got approval to also market Cozaar to ...

Merck Boosts First-Quarter Profits
ABC News - Apr 21, 2003
... During the first quarter, Merck won approval for Emend, to prevent nausea and vomiting
from chemotherapy effects, and got approval to also market Cozaar to ...

Merck Boosts Its 1st-Quarter Profits
Rapid City Journal, SD - Apr 21, 2003
... During the first quarter, Merck won approval for Emend, to prevent nausea and vomiting
from chemotherapy effects, and got approval to also market Cozaar to ...

Merck boosts first-quarter profits on higher sales
Newsday - Apr 21, 2003
... During the first quarter, Merck won approval for Emend, to prevent nausea and vomiting
from chemotherapy effects, and got approval to also market Cozaar to ...

Merck Profit Rises on Higher Drug Sales
MSN Money - Apr 21, 2003
... effectiveness . Merck last month received approval to sell Emend, a drug
to prevent nausea and vomiting among patients taking chemotherapy. ...

UPDATE 4-Merck quarterly profit rises on higher drug sales
Reuters, UK - Apr 21, 2003
... effectiveness . Merck last month received approval to sell Emend, a drug
to prevent nausea and vomiting among patients taking chemotherapy. ...

Merck Profit Rises on Higher Drug Sales
Reuters, UK - Apr 21, 2003
... effectiveness . Merck last month received approval to sell Emend, a drug
to prevent nausea and vomiting among patients taking chemotherapy. ...

Merck Boosts Its 1st-Quarter Profits
The Porterville Recorder, CA - Apr 21, 2003
... During the first quarter, Merck won approval for Emend, to prevent nausea and vomiting
from chemotherapy effects, and got approval to also market Cozaar to ...

Merck Boosts Its 1st-Quarter Profits
Springfield News Sun, OH - Apr 21, 2003
... During the first quarter, Merck won approval for Emend, to prevent nausea and vomiting
from chemotherapy effects, and got approval to also market Cozaar to ...

Shares narrowly mixed ahead of earnings
Washington Times, DC - Apr 21, 2003
... Over the past three months, the world's third-largest drug company launched Emend,
a medicine that helps prevent nausea in cancer chemotherapy, and it also ...

Merck Boosts Its 1st-Quarter Profits
Seattle Times, WA - Apr 21, 2003
... During the first quarter, Merck won approval for Emend, to prevent nausea and vomiting
from chemotherapy effects, and got approval to also market Cozaar to ...

Merck Boosts Its 1st-Quarter Profits
ABC News - Apr 21, 2003
... During the first quarter, Merck won approval for Emend, to prevent nausea and vomiting
from chemotherapy effects, and got approval to also market Cozaar to ...

Merck reports first-quarter gains
Washington Times, DC - Apr 21, 2003
Over the past three months, the world's third-largest drug company launched Emend,
a medicine that helps prevent nausea in cancer chemotherapy, and it also ...

Shares narrowly mixed ahead of earnings
United Press International - Apr 21, 2003
... Over the past three months, the world's third-largest drug company launched Emend,
a medicine that helps prevent nausea in cancer chemotherapy, and it also ...

Merck Profit Rises on Higher Drug Sales
MSN Money - Apr 21, 2003
... effectiveness . Last month Merck received approval to sell Emend, a drug
to prevent nausea and vomiting among patients taking chemotherapy. ...

Merck Profit Rises on Higher Drug Sales
Reuters, UK - Apr 21, 2003
... effectiveness . Last month Merck received approval to sell Emend, a drug
to prevent nausea and vomiting among patients taking chemotherapy. ...

UPDATE 3-Merck quarterly profit rises on higher drug sales
Reuters, UK - Apr 21, 2003
... effectiveness . Last month Merck received approval to sell Emend, a drug
to prevent nausea and vomiting among patients taking chemotherapy. ...

Merck Profit Rises on Higher Drug Sales
Reuters, UK - Apr 21, 2003
... effectiveness . Last month Merck received approval to sell Emend, a drug
to prevent nausea and vomiting among patients taking chemotherapy. ...

Merck reports first-quarter gains
United Press International - Apr 21, 2003
Over the past three months, the world's third-largest drug company launched Emend,
a medicine that helps prevent nausea in cancer chemotherapy, and it also ...

Merck Profit Rises on Higher Drug Sales
MSN Money - Apr 21, 2003
... issues. Merck won approval last month for Emend, a drug to prevent nausea
and vomiting among patients taking chemotherapy. Regulators ...

Merck Profit Rises on Higher Drug Sales
Reuters, UK - Apr 21, 2003
... issues. Merck won approval last month for Emend, a drug to prevent nausea
and vomiting among patients taking chemotherapy. Regulators ...

Merck Profit Rises on Higher Drug Sales
Reuters, UK - Apr 21, 2003
... issues. Merck won approval last month for Emend, a drug to prevent nausea
and vomiting among patients taking chemotherapy. Regulators ...

Merck ’ s profit rises
MSNBC - Apr 21, 2003
... Singulair. Merck won approval last month for Emend, a drug to prevent
nausea and vomiting among patients taking chemotherapy. Regulators ...

Merck Meets Estimates on Strength of Core Drugs
Smart Money - Apr 21, 2003
... The company noted that the Food and Drug Administration in March approved Emend
for the prevention of nausea and vomiting associated cancer chemotherapy, and ...

Merck profit rises on sales of key drugs
USA Today - Apr 21, 2003
... Singulair. Merck won approval last month for Emend, a drug to prevent
nausea and vomiting among patients taking chemotherapy. Regulators ...

Merck's 1Q Profit Rose 5.2% on Strength of Core Drugs
Quicken - Apr 21, 2003
... The company noted that the Food and Drug Administration in March approved Emend
for the prevention of nausea and vomiting associated cancer chemotherapy, and ...

Merck Profit Rises on Sales of Key Drugs
Reuters, UK - Apr 21, 2003
... Singulair. Merck won approval last month for Emend, a drug to prevent
nausea and vomiting among patients taking chemotherapy. Regulators ...

UPDATE 1-Merck profit rises on sales of key drugs
Reuters, UK - Apr 21, 2003
... Singulair. Merck won approval last month for Emend, a drug to prevent
nausea and vomiting among patients taking chemotherapy. Regulators ...

Merck Announces First - Quarter 2003 Earnings Per Share - EPS - ...
Business Wire (press release) - Apr 21, 2003
... In March, the US Food and Drug Administration (FDA) approved EMEND, the first member
in a new class of medicines to help prevent the acute and delayed nausea ...

FDA Approves Emend (Aprepitant) To Combat Nausea And Vomiting ...
Doctor's Guide, NY - Apr 1, 2003
BETHESDA, MD -- April 1, 2003 -- The Food and Drug Administration (FDA) announced
the approval of a new drug called Emend (aprepitant), to be used in ...

FDA CAPSULES
Newsday - Apr 1, 2003
... impulses in the brain. The FDA cleared sale last week of Emend, the first
drug approved to prevent delayed nausea. A number of existing ...

This Week In Health
Intelihealth.com, PA - Mar 28, 2003
... The new drug, Emend, can prevent a less common type of nausea that
occurs a day or so later. Emend works by blocking the receptors ...